BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27180034)

  • 1. Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.
    Fotiadis P; van Rooden S; van der Grond J; Schultz A; Martinez-Ramirez S; Auriel E; Reijmer Y; van Opstal AM; Ayres A; Schwab KM; ; Hedden T; Rosand J; Viswanathan A; Wermer M; Terwindt G; Sperling RA; Polimeni JR; Johnson KA; van Buchem MA; Greenberg SM; Gurol ME
    Lancet Neurol; 2016 Jul; 15(8):811-819. PubMed ID: 27180034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study.
    van Opstal AM; van Rooden S; van Harten T; Ghariq E; Labadie G; Fotiadis P; Gurol ME; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; van der Grond J
    Lancet Neurol; 2017 Feb; 16(2):115-122. PubMed ID: 27989553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.
    Subotic A; McCreary CR; Saad F; Nguyen A; Alvarez-Veronesi A; Zwiers AM; Charlton A; Beaudin AE; Ismail Z; Pike GB; Smith EE
    J Alzheimers Dis; 2021; 81(4):1663-1671. PubMed ID: 33998545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
    Charidimou A; Boulouis G; Frosch MP; Baron JC; Pasi M; Albucher JF; Banerjee G; Barbato C; Bonneville F; Brandner S; Calviere L; Caparros F; Casolla B; Cordonnier C; Delisle MB; Deramecourt V; Dichgans M; Gokcal E; Herms J; Hernandez-Guillamon M; Jäger HR; Jaunmuktane Z; Linn J; Martinez-Ramirez S; Martínez-Sáez E; Mawrin C; Montaner J; Moulin S; Olivot JM; Piazza F; Puy L; Raposo N; Rodrigues MA; Roeber S; Romero JR; Samarasekera N; Schneider JA; Schreiber S; Schreiber F; Schwall C; Smith C; Szalardy L; Varlet P; Viguier A; Wardlaw JM; Warren A; Wollenweber FA; Zedde M; van Buchem MA; Gurol ME; Viswanathan A; Al-Shahi Salman R; Smith EE; Werring DJ; Greenberg SM
    Lancet Neurol; 2022 Aug; 21(8):714-725. PubMed ID: 35841910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent hemorrhage risk and mortality in hereditary and sporadic cerebral amyloid angiopathy.
    van Etten ES; Gurol ME; van der Grond J; Haan J; Viswanathan A; Schwab KM; Ayres AM; Algra A; Rosand J; van Buchem MA; Terwindt GM; Greenberg SM; Wermer MJ
    Neurology; 2016 Oct; 87(14):1482-1487. PubMed ID: 27590282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    van Harten TW; Heijmans A; van Rooden S; Wermer MJH; van Osch MJP; Kuijf HJ; van Veluw SJ; Greenberg SM; van Buchem MA; van der Grond J; van Walderveen MAA
    J Alzheimers Dis; 2022; 90(1):381-388. PubMed ID: 36120778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediators of cognitive impairment in cerebral amyloid angiopathy.
    Durrani R; Wang M; Cox E; Irving E; Saad F; McCreary CR; Beaudin AE; Gee M; Nelles K; Sajobi TT; Ismail Z; Camicioli R; Smith EE
    Int J Stroke; 2023 Jan; 18(1):78-84. PubMed ID: 35473418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
    Castellani RJ; Smith MA; Perry G; Friedland RP
    Neurobiol Aging; 2004; 25(5):599-602; discussion 603-4. PubMed ID: 15172735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative Magnetic Resonance Imaging Markers of Hereditary Cerebral Amyloid Angiopathy at 7 Tesla.
    Koemans EA; van Etten ES; van Opstal AM; Labadie G; Terwindt GM; Wermer MJH; Webb AG; Gurol EM; Greenberg SM; van Buchem MA; van der Grond J; van Rooden S
    Stroke; 2018 Jun; 49(6):1518-1520. PubMed ID: 29695466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perivascular Spaces Volume in Sporadic and Hereditary (Dutch-Type) Cerebral Amyloid Angiopathy.
    Martinez-Ramirez S; van Rooden S; Charidimou A; van Opstal AM; Wermer M; Gurol ME; Terwindt G; van der Grond J; Greenberg SM; van Buchem M; Viswanathan A
    Stroke; 2018 Aug; 49(8):1913-1919. PubMed ID: 30012821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophy patterns in cerebral amyloid angiopathy with and without cortical superficial siderosis.
    Kim J; Na HK; Shin JH; Kim HJ; Seo SW; Seong JK; Na DL
    Neurology; 2018 May; 90(20):e1751-e1758. PubMed ID: 29678935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy.
    Koemans EA; Voigt S; Rasing I; van Harten TW; Jolink WMT; Schreuder FHBM; van Zwet EW; van Buchem MA; van Osch MJP; Terwindt GM; Klijn CJM; van Walderveen MAA; Wermer MJH
    Stroke; 2022 Feb; 53(2):552-557. PubMed ID: 34538086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) contains various extracellular matrix deposits.
    van Duinen SG; Maat-Schieman ML; Bruijn JA; Haan J; Roos RA
    Lab Invest; 1995 Aug; 73(2):183-9. PubMed ID: 7637318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers.
    Schouten TM; de Vos F; van Rooden S; Bouts MJRJ; van Opstal AM; Feis RA; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; de Rooij M; Rombouts SARB; van der Grond J
    J Am Heart Assoc; 2019 Feb; 8(3):e011288. PubMed ID: 30717612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
    van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
    Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
    Planton M; Saint-Aubert L; Raposo N; Payoux P; Salabert AS; Albucher JF; Olivot JM; Péran P; Pariente J
    J Alzheimers Dis; 2020; 73(4):1607-1614. PubMed ID: 31958082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update.
    Farid K; Charidimou A; Baron JC
    Neuroimage Clin; 2017; 15():247-263. PubMed ID: 28560150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
    Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
    Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
    Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.